Search Results 541-550 of 21245 for anti-TNF drugs

  1. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

    Patient is currently receiving anti-TNF treatment for ≤12 months. Patient must receive anti-TNF treatment within 2 months following enrollment into the ...

  2. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

    Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell ...

  3. Secukinumab (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Secukinumab injection is used to treat moderate to severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) ...

  4. Infliximab-Abda (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  5. Lenalidomide (Oral Route) Description and Brand Names - Mayo Clinic

    It is also used as maintenance treatment in patients with multiple myeloma after an autologous hematopoietic stem cell transplant (stem cell transplant that ...

  6. Levoketoconazole (Oral Route) Before Using - Mayo Clinic

    Your doctor may decide not to treat you with this medication or change some of the other medicines you take. ... Adalimumab; Albendazole; Allopurinol; Alprazolam ...

  7. Triamterene And Hydrochlorothiazide (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  8. Antimyasthenic (Oral Route, Parenteral Route) Description and Brand Names - Mayo Clinic

    These medicines are available only with your doctor's prescription. This product is available in the following dosage forms: Tablet, Extended Release; Solution ...

  9. Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation - Mayo Clinic

    Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage ...

  10. A Study to Identify a Panel of Biomarkers to Predict Response to Anti PD-1 Therapy - Mayo Clinic

    The purpose of this study is to identify a panel of possible biomarkers to predict response to anti PD-1 therapy by establishing the progression free survival ...